Recruiting NA Obsessive Compulsive Disorder (OCD)

Compares treatment options for Obsessive Compulsive Disorder (OCD)

Official title Comparative Effectiveness of Internet-based Versus Parent-Coached Cognitive-Behavioral Therapy For Children and Adolescents With Anxiety and OCD

ClinicalTrials.gov ID: NCT07024758

What this study is testing

What it's testing
Anxiety disorders in children and adolescents are common and confer significant disability. Cognitive behavioral therapy (CBT) is the recommended treatment for youth with anxiety, yet many families cannot access CBT due to cost, practicalities of attending in-person treatment sessions, and a shortage of trained providers, especially in rural areas.

A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.

Who can take part

Ages 7 to 17

You may be able to join if

  • The child is between the ages of 7 to 17 years inclusive at enrollment.
  • The child has clinically significant symptoms of anxiety and/or OCD, as indicated by a score of 12 or higher on the Pediatric Anxiety Rating Scale...
  • The child is appropriate for anxiety-focused treatment (e.g., anxiety or OCD is the primary or co-primary problem as diagnosed using the DIAMOND-KID).
  • One parent/guardian is able and willing to participate in assessment and treatment (e.g., has sufficient English fluency, the decisional capacity to...
  • The participating parent/guardian lives with their child at least 50% of the time per self-report.

You likely can't join if

  • The child has a diagnosis of a lifetime psychotic disorder and/or conduct disorder.
  • The child has significant, current and active suicidality/homicidality and/or self-injury requiring medical intervention.
  • The child has limited verbal communication abilities (e.g., no independent verbal communication).
  • The child is receiving concurrent psychotherapy with anxiety and/or OCD as the primary focus. They can pause ongoing therapy to enroll.
  • The child has initiated new antidepressant medication within 12-weeks of assessment (4-weeks for stimulants/benzodiazepines/antipsychotics) or during...
  • The child has changed psychotropic medication dosage within 4-weeks of assessment (2-weeks for stimulants/benzodiazepines/antipsychotics) or during...
See the full eligibility criteria
Who can join
  • The child is between the ages of 7 to 17 years inclusive at enrollment.
  • The child has clinically significant symptoms of anxiety and/or OCD, as indicated by a score of 12 or higher on the Pediatric Anxiety Rating Scale (PARS).
  • The child is appropriate for anxiety-focused treatment (e.g., anxiety or OCD is the primary or co-primary problem as diagnosed using the DIAMOND-KID).
  • One parent/guardian is able and willing to participate in assessment and treatment (e.g., has sufficient English fluency, the decisional capacity to participate, and can commit to treatment duration).
  • The participating parent/guardian lives with their child at least 50% of the time per self-report.
  • Both parent and child can read and understand English.
  • The participant has an IQ above 69, based on the KBIT-2, another valid test or clinician judgement (e.g., a previous assessment conducted, and report shared with study team).
  • Participants must be in the state of Texas for treatment sessions/assessments.
What rules you out
  • The child has a diagnosis of a lifetime psychotic disorder and/or conduct disorder.
  • The child has significant, current and active suicidality/homicidality and/or self-injury requiring medical intervention.
  • The child has limited verbal communication abilities (e.g., no independent verbal communication).
  • The child is receiving concurrent psychotherapy with anxiety and/or OCD as the primary focus. They can pause ongoing therapy to enroll.
  • The child has initiated new antidepressant medication within 12-weeks of assessment (4-weeks for stimulants/benzodiazepines/antipsychotics) or during therapy.
  • The child has changed psychotropic medication dosage within 4-weeks of assessment (2-weeks for stimulants/benzodiazepines/antipsychotics) or during therapy.
  • The child requires a higher level of care than can be provided through the study (e.g., significant, current suicidal ideation).

The study team makes the final eligibility decision.

Where it's taking place

  • Houston, Texas, United States

Questions & answers

Do participants get paid in this trial?

This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.

Is it free to join, and do I need insurance?

Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.

How long does this study last?

The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.

Who can join this trial?

This study is enrolling all sexes, 7 years to 17 years. The study team makes the final eligibility decision.

Where is this trial taking place?

Study sites include Houston, Texas, United States. Enter your location above to see the nearest site and check your eligibility.

Explore other conditions

ObesityType 2 diabetesType 1 diabetesPrediabetesWeight lossMetabolic syndromeHigh cholesterolHigh triglyceridesHigh blood pressurePCOSHypothyroidismThyroid diseaseGoutFatty liver disease (NAFLD/NASH)Heart failureCoronary artery disease

BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.